From the fine folks at the DIA …
Supreme Court's Health Care Decision was Announced, Now What Does it Mean for the Biopharmaceutical Industry?
To cure your headache over the sometimes confusing decision and more confusing commentary about the Affordable Care Act Supreme Court decision, hear three veteran health law and policy experts explain what to expect in the wake of the decision. They will detail what the case decided, what changed and what didn’t, then explore how it may affect biopharma companies, as well as the political implications and what Capitol Hill might do next as health reform evolves.
Join us on July 26 from 11:00 AM-12:30 PM ET for the Will the PhRMA Deal Stand and What Happens Next? What the Biopharmaceutical Industry Needs to Know in the Wake of the Supreme Court Decision Upholding the Affordable Care Act webinar where you'll hear experts cut through the hype to consider the real effects of the Supreme Court's decision on the drug, device and biopharma industries.
Moderator: John F. Kamp, JD, PhD Executive Director , Coalition for Healthcare Communication
Presenters: Peter J. Pitts, Former FDA Associate Commissioner President, Center for Medicine in the Public Interest
Arnold I. Friede, Former FDA Associate Chief Counsel, Principal, Arnold I. Friede & Associates
Richard Manning, PhD Partner , Bates White Economic Consulting
Agenda and Event Details
Ellen Diegel, Event Planner